Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data
References (54)
- et al.
Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030
Diabetes Care
(2004) National Diabetes Fact Sheet, United States 2005
(2006)- et al.
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey (NHANES) 1988–1994
Diabetes Care
(1998) - et al.
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
BMJ
(2000) - et al.
The progressive cost of complications in type 2 diabetes mellitus
Arch Intern Med
(1999) - et al.
Potential short-term economic benefits of improved glycemic control: A managed care perspective
Diabetes Care
(2001) - et al.
Effect of improved glycemic control on health care costs and utilization
JAMA
(2001) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Lancet
(1998)The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
N Engl Med
(1993)- et al.
Achievement of American Diabetes Association clinical practice recommendations among US adults with diabetes, 1999–2002: The National Health and Nutrition Examination Survey
Diabetes Care
(2006)
Management of type 2 diabetes in the primary care setting: A practice-based research network study
Ann Fam Med
(2006)
Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002
Ann Intern Med
(2006)
Before oral agents fail: The case for starting insulin early
Int J Obes Relat Metab Disord
(2002)
Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues
Clin Ther
(2005)
Standards of medical care in diabetes
Diabetes Care
(2004)
Update on insulin injection devices
(2006)
FlexPen: Addressing issues of confidence and convenience in insulin delivery
Clin Ther
(2005)
Insulin syringes and pens: Finding the best match for your patients' needs
Clin Diabetes
(1997)
A multicenter, randomized, openlabel, comparative, two-period crossover trial of prefer ence, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus
Clin Ther
(2003)
Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus
Clin Ther
(2004)
Assessment of dose selection attributes with audible notification in insulin pen devices
Diabetes Technol Ther
(2005)
Preference for insulin delivery systems among current insulin users and nonusers
Clin Ther
(2004)
Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe
Clin Ther
(1998)
Patient acceptance and reliability of new Humulin/Humalog 3.0 mL prefilled insulin pen in ten Croatian diabetes centres
Med Sci Monit
(2002)
Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.
Diabetes Res Oin Pract
(1998)
Assessment of quality of treatment in insulin-treated patients with diabetes using a pre-filled insulin pen
Acta Biomed Ateneo Parmense
(2004)
Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies
Diabetes Care
(2004)
Cited by (247)
Insulin Therapy in Small Animals, Part 1: General Principles
2023, Veterinary Clinics of North America - Small Animal PracticeInitiation and intensification of insulin therapy in type 2 diabetes mellitus: Physician barriers and solutions – An Indian perspective
2021, Endocrine and Metabolic ScienceCitation Excerpt :Setting up a peer advisor and patient support groups (Figure 2) helps to improve patient behaviours and disease outcome by providing continuous support and encouraging patients to self-manage diabetes. ( Lee et al., 2006 Oct) In patient support group, people with a common illness can share knowledge and experience following a less hierarchical and more reciprocal relationship than what is developed between patients and health care professionals. To achieve this, physicians must identify a person with diabetes to educate other patients with diabetes in order to build a supportive group.
PERSPECTIVES ON ROBUST DESIGN - AN OVERVIEW OF CHALLENGES AND RESEARCH AREAS ACROSS INDUSTRY FIELDS
2023, Proceedings of the Design SocietyKnowledge and Barriers to Insulin Therapy among Type 2 Diabetes Mellitus Patients from their Perspective
2024, Journal of Chemical Health RisksCentenary of Insulin Therapy: A Review
2024, Current Diabetes ReviewsGuideline Development for Medical Device Technology: Issues for Consideration
2023, Journal of Diabetes Science and Technology
Copyright © 2006 Published by Elsevier Inc.